Test Predicts Primary Resistance to Anti-PD-1 Immunotherapy against Non-Small Cell Lung Cancer
The serum proteomic test could optimize treatment by identifying patients unlikely to benefit from immunotherapy.
Read More
Search Results for: lung cancer
Precipio Expands ICE-COLD PCR Lung Cancer Mutation Detection Offering
New kit examines most relevant EGFR exons that affect therapeutic decisions for lung cancer patients.
Read MoreSignatera Assay Selected for Study of Adjuvant Therapy for Non-Small Cell Lung Cancer
Partners to conduct first study using ctDNA-based minimal residual disease assessment for immunotherapy in the adjuvant non-small cell lung cancer setting.
Read More
Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer
FDA approval allows use of the Therascreen EGFR RGQ PCR kit as a companion diagnostic for Pfizer’s Vizimpro (dacomitinib) in patients with non-small cell lung cancer.
Read More
Researchers Demonstrate Prognostic Value of VeriStrat Testing for Patients with Advanced Lung Cancer
In a study of 1,048 patients, researchers found that the VeriStrat test is a significant predictor of patient outcomes, independent of mutation status, treatment received, and other clinical variables.
Read More